A woman from North Carolina has joined the multidistrict litigation over Xarelto alleging the anticoagulant medication caused her gastrointestinal bleed.
Plaintiff Tandy B. says she took Xarelto for only two months, from October to November 2014. She stopped taking Xarelto around the time she suffered a gastrointestinal bleed. She now alleges that bleed was caused by the blood thinner.
Tandy is filing this Xarelto blood thinner lawsuit against Bayer Pharmaceuticals, Janssen Pharmaceuticals, and Janssen’s parent company Johnson & Johnson. Janssen is the division of J&J responsible for the manufacture, marketing and sales of Xarelto.
Xarelto, also known as rivaroxaban, is a relatively new anticoagulant medication. It has been on the market in the U.S. since first earning FDA approval in 2011.
Xarelto is frequently prescribed to prevent the risk of stroke and systemic embolism in persons with non-valvular atrial fibrillation. It’s also indicated for the treatment and prevention of pulmonary embolism and deep vein thrombosis.
Litigation Over Xarelto
The controversy over Xarelto originates in the risk that Xarelto treatment can lead to excessive bleeding. The same anticoagulant action that makes Xarelto prevent stroke and embolism also inhibits the body’s natural mechanism for slowing and stopping bleeding when it occurs.
This effect can put Xarelto patients at risk for dangerous conditions like a brain hemorrhage or, as in Tandy’s case, a gastrointestinal bleed. Some instances of excessive bleeding have ended in death.
Tandy’s Xarelto blood thinner lawsuit notes that in a set of clinical trials known as the RECORD studies, Xarelto showed more frequent instances of bleeding leading to decreased hemoglobin levels and requiring transfusions of blood.
The claim also cites a later set of trials known as the ROCKET AF study. Results from those trials showed that patients who took Xarelto had more frequent gastrointestinal bleeds.
Tandy is challenging the rationale behind Xarelto’s once a day dosing schedule. The defendants designed and made Xarelto to be taken once a day, making Xarelto treatment simpler and more convenient than treatment with competitor drugs.
However, Tandy cites comments by FDA clinical reviewers questioning the once a day schedule, noting that clinical pharmacology studies suggested that dosing twice a day would produce less variance in Xarelto blood levels. One clinical reviewer suggested that the once a day schedule was promoted more for a marketing advantage than for any clinically significant reason.
A report published by the Institute for Safe Medication Practices also questioned the once a day Xarelto dosing, saying that peaks and dips in the blood level of Xarelto would be better tempered by twice daily dosing.
Tandy also notes that in Xarelto’s first full year on the market, the FDA received no less than 2,081 reports of adverse events associated with Xarelto. Out of those reports, 151 ended in death, Tandy says. She also notes that in the first eight months of 2013, German regulators received 968 reports of Xarelto-related adverse events, 72 of which resulted in death.
Tandy’s Xarelto blood thinner lawsuit is part of the Xarelto multidistrict litigation now pending in the U.S. District Court for the Eastern District of Louisiana under MDL No. 2592.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Xarelto attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Xarelto class action lawsuit is best for you. [In general, Xarelto lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.
Get Help – It’s Free
Join a Free Xarelto Class Action Lawsuit Investigation
If you or a loved one took Xarelto (rivaroxaban) and suffered injuries such as uncontrollable internal bleeding, gastrointestinal bleeding, hemorrhaging, deep vein thrombosis or pulmonary embolism, you may have a legal claim. See if you qualify by filling out the short form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
- First Name*
- Last Name*
- Street Address*
- Apt. #
- City*
- State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
- Zip Code*
- Phone*
- Email*
- Which blood thinner did you or a loved one take at the time of the injury or injuries?*
- Pradaxa
- Xarelto
- Unknown
- Other
- Please check the injuries suffered:*
-
Death
-
Gastrointestinal Bleeding
-
Other Internal Bleeding
-
Cerebral Hemorrhaging
-
Ischemic Stroke
-
Unsure
-
None
-
- ¿Necesita un orador español?
- Yes
- No
- Please enter any additional details you would like the staff reviewing your submission to know.*
- I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
-
Yes
-
-
if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 35) {gformInitChosenFields(‘#input_35_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_35_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_35_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [35, 1]) } );
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2016 Top Class Actions® LLC
Various Trademarks held by their respective owners
The post Xarelto Caused Gastrointestinal Bleed, Lawsuit Says appeared first on Top Class Actions.
No comments:
Post a Comment